Foghorn Therapeutics (FHTX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $16.1 million.
- Foghorn Therapeutics' Other Gross PP&E Adjustments rose 199791.12% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 199791.12%. This contributed to the annual value of -$1.5 million for FY2024, which is 8549.92% up from last year.
- According to the latest figures from Q3 2025, Foghorn Therapeutics' Other Gross PP&E Adjustments is $16.1 million, which was up 199791.12% from $15.4 million recorded in Q2 2025.
- Foghorn Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $22.0 million for Q1 2021, and its period low was -$18.0 million during Q2 2021.
- Over the past 5 years, Foghorn Therapeutics' median Other Gross PP&E Adjustments value was -$6.7 million (recorded in 2023), while the average stood at -$4.4 million.
- In the last 5 years, Foghorn Therapeutics' Other Gross PP&E Adjustments tumbled by 16517.66% in 2022 and then soared by 199791.12% in 2025.
- Foghorn Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$17.0 million in 2021, then increased by 22.15% to -$13.3 million in 2022, then grew by 24.35% to -$10.0 million in 2023, then skyrocketed by 85.5% to -$1.5 million in 2024, then soared by 1205.23% to $16.1 million in 2025.
- Its Other Gross PP&E Adjustments stands at $16.1 million for Q3 2025, versus $15.4 million for Q2 2025 and $5.0 million for Q1 2025.